BTIG Downgrades DexCom (DXCM) to Neutral
- Netflix, Inc. (NFLX) Tops Q4 EPS by 1c; Subs Beat Views
- S&P 500 ends up slightly with boost from financials; Netflix up late
- Nestle Said Examining Takeover of Mead Johnson (MJN) - Source
- La Quinta Holdings (LQ) Gains on Plan to Split in Two
- After-Hours Stock Movers 01/18: (OCLR) (CSX) (NFLX) Higher; (AMDA) (RCII) (ZYNE) Lower (more...)
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
BTIG downgraded DexCom (NASDAQ: DXCM) from Buy to Neutral and removed its price target. Analyst Sean Lavin thinks shares are fairly valued given the stock's run.
"While we do not think shares are overvalued and could argue for a bit more upside as revenue should continue to exceed guidance in our opinion, we do feel a lot of good news is priced in, and given the historical volatility we would like more significant upside than we see at this time to maintain our Buy rating. One additional issue is investors are starting to focus on margins and profitability," said Lavin.
Shares of DexCom closed at $91.88 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Bloomin' Brands (BLMN) to Neutral Citing Margin Pressures And Rising Interest Rate Risks To Interest Expense
- Deutsche Bank Raises Price Target on IHS Markit (INFO) to $44; Reiterates Buy
- Goldman Sachs Downgrades Target (TGT) to Sell, See Structural Challenges
Create E-mail Alert Related CategoriesAnalyst Comments, Downgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!